Cargando…
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike
Neutralizing antibodies targeting the SARS-CoV-2 spike protein have shown a great preventative/therapeutic potential. Here, we report a rapid and efficient strategy for the development and design of SARS-CoV-2 neutralizing humanized nanobody constructs with sub-nanomolar affinities and nanomolar pot...
Autores principales: | Fu, Ying, da Fonseca Rezende e Mello, Juliana, Fleming, Bryan D., Renn, Alex, Chen, Catherine Z., Hu, Xin, Xu, Miao, Gorshkov, Kirill, Hanson, Quinlin, Zheng, Wei, Lee, Emily M., Perera, Lalith, Petrovich, Robert, Pradhan, Manisha, Eastman, Richard T., Itkin, Zina, Stanley, Thomas B., Hsu, Allen, Dandey, Venkata, Sharma, Kedar, Gillette, William, Taylor, Troy, Ramakrishnan, Nitya, Perkins, Shelley, Esposito, Dominic, Oh, Eunkeu, Susumu, Kimihiro, Wolak, Mason, Ferrer, Marc, Hall, Matthew D., Borgnia, Mario J., Simeonov, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365158/ https://www.ncbi.nlm.nih.gov/pubmed/35947606 http://dx.doi.org/10.1371/journal.pone.0272364 |
Ejemplares similares
-
Quantum
Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions
Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis
por: Gorshkov, Kirill, et al.
Publicado: (2020) -
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay
por: Hanson, Quinlin M., et al.
Publicado: (2020) -
Targeting ACE2–RBD Interaction as a Platform
for COVID-19 Therapeutics: Development and Drug-Repurposing Screen
of an AlphaLISA Proximity Assay
por: Hanson, Quinlin M., et al.
Publicado: (2020) -
Nanobodies and recombinant binders in cell biology
por: Helma, Jonas, et al.
Publicado: (2015) -
CAMEL NANOBODIES NEUTRALIZE SARS-COV-2 VARIANTS
por: Hong, Jessica, et al.
Publicado: (2023)